Financial analysis of medical cyclotron facilities

The cyclotron facility must be seen in the context of a market currently served in part by an existing production facility producing a range of complimentary products, some of which are equivalent to those which could be produced in the proposed new cyclotron. The costs assessment area needs to examine the alternative configurations: a 40 MeV unit equipped for medical radioisotope production only, a 16 MeV unit for PET only and a 40 MeV unit for both radioisotope production and PET